Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

25.08.2025

4 Aliment Pharmacol Ther
3 Am J Gastroenterol
1 Am J Surg
3 BMC Gastroenterol
1 BMJ
2 Clin Gastroenterol Hepatol
1 Dig Dis
4 Dig Dis Sci
2 Gastroenterology
16 Inflamm Bowel Dis
2 J Clin Gastroenterol
5 J Crohns Colitis
1 Mediators Inflamm
1 Proc Natl Acad Sci U S A
1 Scand J Gastroenterol


    Aliment Pharmacol Ther

  1. LIN KJ, Hung CH, Wei JC
    Letter: Crohn's Disease or Comorbidity? Reassessing Opioid Prescribing Patterns.
    Aliment Pharmacol Ther. 2025 Aug 23. doi: 10.1111/apt.70311.
    >> Share

  2. OSOOLI M, Olen O
    Letter: Crohn's Disease or Comorbidity? Reassessing Opioid Prescribing Patterns. Authors' Reply.
    Aliment Pharmacol Ther. 2025 Aug 23. doi: 10.1111/apt.70356.
    >> Share

  3. BAYOUMY AB, de Boer NK
    Editorial: Dual Advanced Therapy in Refractory Ulcerative Colitis-Hope Beyond Monotherapy.
    Aliment Pharmacol Ther. 2025 Aug 15. doi: 10.1111/apt.70318.
    >> Share

  4. NEELAM PB, Banerjee R
    Editorial: Dual Advanced Therapy in Refractory Ulcerative Colitis-Hope Beyond Monotherapy. Authors' Reply.
    Aliment Pharmacol Ther. 2025 Aug 15. doi: 10.1111/apt.70339.
    >> Share


    Am J Gastroenterol

  5. YANOFSKY R, McDonald BD, Nikzad N, Choi D, et al
    New Eczematous Eruption in Patients with Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003742.
    >> Share

  6. ANTAYA M, Hudson AS, Lerner EP, Nasser K, et al
    The impact of integrating pelvic MRI at diagnosis on early detection of perianal Crohn's disease in pediatrics.
    Am J Gastroenterol. 2025 Aug 20. doi: 10.14309/ajg.0000000000003733.
    >> Share

  7. ZHANG Q, Liu H, Liu S, Zhu S, et al
    Increased mortality associated with sarcopenia in inflammatory bowel disease: a long-term prospective cohort study.
    Am J Gastroenterol. 2025 Aug 20. doi: 10.14309/ajg.0000000000003734.
    >> Share


    Am J Surg

  8. SHAHAM D, Naveh S, Zemel M, Kariv Y, et al
    Smokers with Crohn's face worse surgical outcomes: A 90-day perioperative analysis.
    Am J Surg. 2025;247:116458.
    >> Share


    BMC Gastroenterol

  9. NAGHSH N, Karimi F, Tarrahi MJ, Rahimi A, et al
    Evaluation of the association between periodontitis and inflammatory bowel disease: A systematic review and Meta-analysis.
    BMC Gastroenterol. 2025;25:594.
    >> Share

  10. KOIFMAN E, Cohen IS, Lopez-Alonso R, Hur DB, et al
    Mesenteric fat proliferation on magnetic resonance enterography is a predictor of long-term disease complications in crohn's disease.
    BMC Gastroenterol. 2025;25:593.
    >> Share

  11. BURTON AM, Perler BK
    Mobile health technologies in inflammatory bowel disease: a narrative review.
    BMC Gastroenterol. 2025;25:595.
    >> Share


    BMJ

  12. O'DOWD A
    NICE approves new treatment for inflammatory bowel disease.
    BMJ. 2025;390:r1759.
    >> Share


    Clin Gastroenterol Hepatol

  13. BUISSON A, Serrero M, Altwegg R, Guilmoteau T, et al
    Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS study.
    Clin Gastroenterol Hepatol. 2025 Aug 18:S1542-3565(25)00700.
    >> Share

  14. CAI L, Wittrup E, Minoccheri C, Hiatt T, et al
    Artificial Intelligence for Quantifying Endoscopic Mucosal Ulceration in Crohn's Disease.
    Clin Gastroenterol Hepatol. 2025 Aug 18:S1542-3565(25)00655.
    >> Share


    Dig Dis

  15. REGUEIRO M, Gulati T, Bandyopadhyay A, Fisher DA, et al
    Real-world Dose Escalation and Associated Direct Costs of Biologics in Management of Ulcerative Colitis: A Retrospective Database Study.
    Dig Dis. 2025 Aug 16:1-16. doi: 10.1159/000547994.
    >> Share


    Dig Dis Sci

  16. DAI F, Ye S, Zhu Y, Zhang J, et al
    Identification of Inflammation-Related Diagnostic Biomarker and Molecular Subtypes in Ulcerative Colitis Based on Machine Learning.
    Dig Dis Sci. 2025 Aug 26. doi: 10.1007/s10620-025-09312.
    >> Share

  17. WENG J, Alizadeh M, Friedman S
    Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Aug 19. doi: 10.1007/s10620-025-09344.
    >> Share

  18. MENCHEN L
    Gaining the Upper Hand - Upadacitinib for Crohn's Disease with Ileostomy: A Real-World Gap Addressed.
    Dig Dis Sci. 2025 Aug 14. doi: 10.1007/s10620-025-09313.
    >> Share

  19. ALSAKARNEH S, Camilleri M, Farraye FA, Hashash JG, et al
    Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Acute Pouchitis: A Matched Cohort Study from the United States.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09039.
    >> Share


    Gastroenterology

  20. MOULI VP, Kedia S, Sharma V, Pulimood AB, et al
    Navigating the Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease.
    Gastroenterology. 2025 Aug 19:S0016-5085(25)05883.
    >> Share

  21. STIDHAM RW, Ghanem LR, Fletcher JG, Bruining DH, et al
    Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease Assessment and Study Management.
    Gastroenterology. 2025;169:432-443.
    >> Share


    Inflamm Bowel Dis

  22. LERCHOVA T, Ludvigsson J, Marild S, Imberg H, et al
    Early-Life Body Mass Index and Inflammatory Bowel Disease Risk: A Scandinavian Birth Cohort Study.
    Inflamm Bowel Dis. 2025 Aug 25:izaf167. doi: 10.1093.
    >> Share

  23. YARUR AJ, Chiorean MV, Allegretti JR, Cross RK, et al
    Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program.
    Inflamm Bowel Dis. 2025;31:2144-2153.
    >> Share

  24. BOUWKNEGT DG, van der Weide AHC, Dijkstra G, Goetgebuer RL, et al
    Pregnancy With a Stoma is Feasible, Though Associated With Manageable Complications.
    Inflamm Bowel Dis. 2025;31:2195-2203.
    >> Share

  25. LEWIN S, Long M, Cohen R, Scherl E, et al
    Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry.
    Inflamm Bowel Dis. 2025;31:2106-2111.
    >> Share

  26. JIANG M, Jia Y, Ma C, Zeng Z, et al
    Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway.
    Inflamm Bowel Dis. 2025;31:2217-2230.
    >> Share

  27. LUSHNIKOVA A, Wickbom A, Bohr J, Kruse R, et al
    Increased Colonic Levels of CD8+ Cytotoxic T lymphocyte-Associated Mediators in Patients With Microscopic Colitis.
    Inflamm Bowel Dis. 2025;31:2231-2243.
    >> Share

  28. LEE SH, Lopes E, Colombel JF, Ungaro R, et al
    Identifying Potential Targets for the Interception of Inflammatory Bowel Disease: Toward Precision Prevention.
    Inflamm Bowel Dis. 2025 Aug 20:izaf168. doi: 10.1093.
    >> Share


  29. Correction to: A Role for Leucine-Rich alpha2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Aug 25:izaf198. doi: 10.1093.
    >> Share

  30. EREN DURMUS M, Koker G
    Comment on "Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2025 Aug 23:izaf192. doi: 10.1093.
    >> Share

  31. ZHOU R, Bai X, Zhang D, Zhu Y, et al
    Role of lncRNA MGP202 in Modulating B Cell Dynamics and Its Implications in Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Aug 23:izaf176. doi: 10.1093.
    >> Share

  32. MAR JS, Nguyen A, Scherl A, Wittke M, et al
    InflammationBacterial Dysbiosis Observed in the Terminal Ileum of Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Aug 22:izaf160. doi: 10.1093.
    >> Share

  33. BOYD T, Friedman S, Newman KL, Chedid V, et al
    Sexual Health Concerns and Health Care Experiences of LGBTQ+ Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Aug 21:izaf158. doi: 10.1093.
    >> Share

  34. SWAMINATHAN A, Hou D, Borichevsky GM, Kettle AJ, et al
    Author's Response to Comment on "Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2025 Aug 21:izaf189. doi: 10.1093.
    >> Share

  35. NOVIELLO D, Atreya R, Noor NM
    Resolving Loss of Response to Ustekinumab in Crohn's Disease: POWER Through or Switch Treatment?
    Inflamm Bowel Dis. 2025 Aug 20:izaf179. doi: 10.1093.
    >> Share

  36. BAKER NM, Soltero KS, Ebriani J, Dalal RS, et al
    Clinical Characteristics and Treatment Patterns in a Large Cohort of Patients with Metastatic Crohn's Disease.
    Inflamm Bowel Dis. 2025 Aug 20:izaf164. doi: 10.1093.
    >> Share

  37. YERUSHALMY-FELER A, Spencer EA, Bergstein S, Mitrova K, et al
    Real-World Experience with Upadacitinib for Pediatric Acute Severe Ulcerative Colitis: An International Multicenter Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2025 Aug 20:izaf166. doi: 10.1093.
    >> Share


    J Clin Gastroenterol

  38. GRAY JK, Guo B, Baniahmad A, Odat B, et al
    Fecal Short and Branched Chain Acids as Possible Biomarkers for Inflammatory Bowel Disease and UC and CD Subgroups? A Case-Control Study.
    J Clin Gastroenterol. 2025 Aug 18. doi: 10.1097/MCG.0000000000002237.
    >> Share

  39. CUMMINGS F, Smith PJ, Fumery M, Rahmany S, et al
    Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.
    J Clin Gastroenterol. 2025 Aug 6. doi: 10.1097/MCG.0000000000002228.
    >> Share


    J Crohns Colitis

  40. ROBLIN X, Vieujean S, Nancey S, Hebuterne X, et al
    Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.
    J Crohns Colitis. 2025;19:jjaf115.
    >> Share

  41. LIM CT, Teichert C, Pruijt M, De Voogd F, et al
    Transmural healing in ulcerative colitis patients improves long-term outcomes compared to endoscopic healing alone.
    J Crohns Colitis. 2025 Aug 22:jjaf149. doi: 10.1093.
    >> Share

  42. MASSIRONI S, Solitano V, Furfaro F, D'Amico F, et al
    Impact of Type 2 Diabetes on Clinical Outcomes and Advanced Therapy Use in Patients with Crohn's Disease: a Real-World Propensity Score-Matched Analysis.
    J Crohns Colitis. 2025 Aug 21:jjaf157. doi: 10.1093.
    >> Share

  43. HAANAPPEL AEG, Moojen TB, Vlug MS, Hompes R, et al
    Impact of advanced therapies on surgical recurrence following second ileocolic resection in Crohn's disease.
    J Crohns Colitis. 2025 Aug 21:jjaf156. doi: 10.1093.
    >> Share

  44. BAK MTJ, Boland K, Nayeri S, Borowksi K, et al
    Micronutrients are associated with endoscopic postoperative recurrence in Crohn's disease: a multicenter prospective cohort study in North america.
    J Crohns Colitis. 2025 Aug 20:jjaf148. doi: 10.1093.
    >> Share


    Mediators Inflamm

  45. HE L, Wei J, Li Z, Guo S, et al
    Immunocytes Mediate the Effects of Gut Microbiome on Inflammatory Bowel Disease: Insights From a Mendelian Randomization Study.
    Mediators Inflamm. 2025;2025:9956259.
    >> Share


    Proc Natl Acad Sci U S A

  46. PARK JD, Lee SR, Dhennezel C, Taylor N, et al
    Elucidating the role of Campylobacter concisus-derived indole metabolites in gut inflammation and immune modulation.
    Proc Natl Acad Sci U S A. 2025;122:e2514071122.
    >> Share


    Scand J Gastroenterol

  47. LIM S, Kim KW, Moon JS, Kim SH, et al
    Tight monitoring with colonoscopy and magnetic resonance enterography improves outcomes in patients with Crohn's disease.
    Scand J Gastroenterol. 2025 Aug 22:1-12. doi: 10.1080/00365521.2025.2544307.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016